Genzyme, Industry Analysts Relieved By Particulars In Draft Consent Decree
This article was originally published in The Pink Sheet Daily
Executive Summary
Unveiling its first-quarter financial results, Genzyme reports significant year-over-year sales decreases for Cerezyme and Fabrazyme.